Physician profile
Bobby Tullos
NPI 1841554250
$276,456.27
in general payments reported to CMS, 2019-2025
65 companies · $55K in 2025
The $55K reported for 2025 was more than what 98% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $17K · 2021: $34K · 2022: $49K · 2023: $66K · 2024: $35K · 2025: $55K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $76K · Education: $27K · Consulting Fee: $19K · Food and Beverage: $18K · Travel and Lodging: $14K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $76,481.75 |
| Education | $27,386.19 |
| Consulting Fee | $18,970.00 |
| Food and Beverage | $18,306.19 |
| Travel and Lodging | $14,254.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $141,977.97 | 2019-2025 | Arexvy, Trelegy Ellipta, Nucala |
| Intuitive Surgical, INC. | $33,650.20 | 2023-2025 | Da Vinci Surgical System |
| Mylan Specialty L.P. | $31,537.96 | 2019-2024 | Yupelri, Yupelri |
| Olympus America INC. | $19,591.80 | 2023-2025 | Spiration Valve System, Single-Use Flexible Video Bronchoscope |
| United Therapeutics Corporation | $18,598.13 | 2019-2025 | Tyvaso, Tyvaso, Remodulin |
| Pinnacle Biologics, INC | $4,725.33 | 2022-2024 | Photofrin |
| Genzyme Corporation | $4,136.90 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $3,032.76 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,541.41 | 2019-2025 | Ofev, Jascayd, Spiriva Respimat |
| Ambu INC. | $2,174.78 | 2024-2025 | |
| Veran Medical Technologies, INC. | $1,945.50 | 2019 | |
| Viiv Healthcare Company | $1,600.00 | 2019 | |
| Medical Device Business Services, INC. | $1,077.45 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $1,007.44 | 2021-2025 | Dupixent |
| Noah Medical Corporation | $979.75 | 2023-2025 | Galaxy |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $959.92 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Grifols USA, LLC | $803.81 | 2020-2025 | Prolastin-C Liquid |
| Mallinckrodt Hospital Products INC. | $692.65 | 2022-2025 | Acthar |
| Ethicon INC. | $419.60 | 2020-2023 | Monarch Platform |
| Merck Sharp & Dohme LLC | $407.47 | 2019-2025 | Winrevair, Recarbrio, Dificid |
| Ani Pharmaceuticals, INC. | $379.83 | 2023-2025 | Purified Cortrophin Gel |
| Insmed, INC. | $375.03 | 2019-2025 | Arikayce, Brinsupri |
| Takeda Pharmaceuticals U.S.A., INC. | $365.51 | 2022-2025 | Glassia |
| Baxter Healthcare | $325.97 | 2022-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Janssen Pharmaceuticals, INC | $238.07 | 2020-2023 | Xarelto |
| Genentech USA, INC. | $234.95 | 2019-2023 | Xolair |
| Bayer Healthcare Pharmaceuticals INC. | $229.83 | 2019-2024 | |
| Sunovion Pharmaceuticals INC. | $209.54 | 2019 | |
| Gilead Sciences, INC. | $175.35 | 2019-2024 | Veklury |
| Electromed, INC. | $169.17 | 2022-2025 | Smartvest |
| Astellas Pharma US INC | $149.07 | 2019-2025 | Cresemba |
| Verona Pharma, INC. | $148.66 | 2025 | Ohtuvayre |
| Amgen INC. | $148.19 | 2022-2024 | Tezspire |
| Advanced Respiratory, INC | $126.11 | 2020-2021 | |
| Fisher & Paykel Healthcare INC | $121.00 | 2021 | |
| Philips North America LLC | $110.56 | 2023-2025 | Vest Therapy Und |
| Portola Pharmaceuticals, LLC | $108.08 | 2019-2020 | |
| Harmony Biosciences LLC | $98.05 | 2020 | |
| Getinge USA Sales, LLC | $95.28 | 2020-2021 | |
| Medtronic, INC. | $86.24 | 2023 | Illumisite |
| Novartis Pharmaceuticals Corporation | $81.21 | 2019-2020 | |
| Gyrus Acmi, INC. | $59.58 | 2025 | Spiration Valve System |
| Medtronic USA, INC. | $58.59 | 2019 | |
| Mallinckrodt Enterprises LLC | $52.87 | 2019 | |
| La Jolla Pharmaceutical Company | $38.44 | 2019-2023 | Giapreza |
| Paratek Pharmaceuticals, INC. | $38.23 | 2021-2024 | Nuzyra |
| Jazz Pharmaceuticals INC. | $28.12 | 2019 | |
| Apria Healthcare LLC | $27.19 | 2021 | |
| Daiichi Sankyo INC. | $26.38 | 2024 | Injectafer |
| Abbott Laboratories | $26.34 | 2021 | |
| Liquidia Technologies, INC. | $26.25 | 2025 | Yutrepia |
| Viatris Specialty LLC | $25.56 | 2025 | Yupelri |
| Alexion Pharmaceuticals, INC. | $23.44 | 2022 | |
| Nabriva Therapeutics, Plc | $21.70 | 2021 | |
| Mauna Kea Technologies, INC. | $20.88 | 2023 | |
| Caris Mpi, INC. | $20.67 | 2025 | Mi Cancer Seek |
| Biofire Diagnostics, LLC | $19.49 | 2021 | |
| Livanova USA, INC. | $18.96 | 2020 | |
| Tetraphase Pharmaceuticals, INC. | $18.41 | 2019 | |
| Pfizer INC. | $15.34 | 2023 | |
| Janssen Biotech, INC. | $14.77 | 2019 | |
| Pulmonx Corporation | $13.94 | 2025 | Chartis Catheter, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Elutia, INC. | $12.91 | 2020 | |
| Bard Peripheral Vascular, INC. | $11.68 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bobby Tullos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.